Increased PK11195 PET binding in the cortex of patients with MS correlates with disability

Neurology

Volumn 79, Issue 6, 2012, Pages 523-530

  Politis, Marios ^a,b   Giannetti, Paolo ^a,b   Su, Paul ^a,b   Turkheimer, Federico ^a,b   Keihaninejad, Shiva ^b,c   Wu, Kit ^a,b   Waldman, Adam ^a,b   Malik, Omar ^d   Matthews, Paul M ^a   Reynolds, Richard ^a   Nicholas, Richard ^a,d   Piccini, Paola ^a,b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISABILITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FUSIFORM GYRUS; GRAY MATTER; HUMAN; IN VIVO STUDY; INFERIOR TEMPORAL GYRUS; LINGUAL GYRUS; MALE; MIDDLE FRONTAL GYRUS; MIDDLE TEMPORAL GYRUS; MULTIPLE SCLEROSIS; ORBITAL CORTEX; PARAHIPPOCAMPAL GYRUS; PARIETAL GYRUS; POSITRON EMISSION TOMOGRAPHY; POSTCENTRAL GYRUS; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; SUPERIOR TEMPORAL GYRUS; WHITE MATTER;

EID: 84866117533     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182635645     Document Type: Article

References (40)

1. Peterson JW, Bö L,Mörk S, Chang A, Trapp BD. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001;50:389-400.
2. Bø L, Vedeler CA, Nyland H, Trapp BD, Mørk SJ. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 2003;9:323-331.
3. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005;128:2705-2712.
4. Wegner C, Esiri MM, Chance SA, Palace J, Matthews PM. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 2006;67:960 -967.
5. Magliozzi R, Howell O, Vora A, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007;130:1089 -1104.
6. Magliozzi R, Howell OW, Reeves C, et al. A gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 2010;68:477-493.
7. Cifelli A, Arridge M, Jezzard P, Esiri MM, Palace J, Matthews PM. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002;52:650-653.
8. Calabrese M, Rocca MA, Atzori M, et al. A three year study of cortical lesions in relapse-onset multiple sclerosis. Ann Neurol 2010;67:376 -383.
9. Schmierer K, Parkes HG, So PW, et al. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis. Brain 2010;133:858-867.
10. Geurts JJ, Barkhof F. Grey matter pathology in multiple sclerosis. Lancet Neurol 2008;7:841-851.
11. Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 2004;55:458-468.
12. Lassmann H. Multiple sclerosis: is there neurodegeneration independent from inflammation? J Neurol Sci 2007; 259:3-6.
13. Zipp F, Aktas O. The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci 2006;29:518 -527.
14. Dutta R, McDonough J, Yin X, et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 2006;59:478-489.
15. Dal Bianco A, Bradl M, Frischer J, Kutzelnigg A, Jellinger K, Lassmann H. Multiple sclerosis and Alzheimer's disease. Ann Neurol 2008;63:174 -183.
16. Banati RB. Visualising microglial activation in vivo. Glia 2002;40:206 -217.
17. Banati RB, Newcombe J, Gunn RN, et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 2000;123:2321-2337.
18. Debruyne JC, Versijpt J, Van Laere KJ, et al. PET visualization of microglia in multiple sclerosis patients using [11C]PK11195. Eur J Neurol 2003;10:257-264.
19. Versijpt J, Debruyne JC, Van Laere KJ, et al. Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study. Mult Scler 2005;11:127-134.
20. Venneti S, Lopresti BJ, Wiley CA. The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging. Prog Neurobiol 2006;80: 308-322.
21. Turkheimer FE, Edison P, Pavese N, et al. Reference and target region modeling of [11C]-(R)-PK11195 brain studies. J Nucl Med 2007;48:158 -167.
22. Boellaard R, Turkheimer FE, Hinz R, et al. Performance of a modified supervised cluster algorithm for extracting reference region input functions from (R)-[C-11]PK11195 brain PET studies. IEEE 2009; IEEE Nuclear Science Symposium/Medical Imaging Conference; 4666-4668.
23. Heckemann RA, Keihaninejad S, Aljabar P, Rueckert D, Hajnal JV, Hammers A, Alzheimer's Disease Neuroimaging Initiative. Improving intersubject image registration using tissue-class information benefits robustness and accuracy of multi-atlas based anatomical segmentation. Neuroimage 2010;51:221-227.
24. Kemp BJ, Kim C, Williams JJ, Ganin A, Lowe VJ, National Electrical Manufacturers Association (NEMA). NEMA NU 2-2001 performance measurements of an LYSO-based PET/CT system in 2D and 3D acquisition modes. J Nucl Med 2006;47:1960 -1967.
25. Hammers A, Chen CH, Lemieux L, et al. Statistical neuroanatomy of the human inferior frontal gyrus and probabilistic atlas in a standard stereotaxic space. Hum Brain Mapp 2007;28:34-48.
26. Hammers A, Allom R, Koepp MJ, et al. Threedimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp 2003;19:224 -247.
27. Gousias IS, Rueckert D, Heckemann RA, et al. Automatic segmentation of brain MRIs of 2-year-olds into 83 regions of interest. Neuroimage 2008;40:672-684.
28. Heckemann RA, Hajnal JV, Aljabar P, Rueckert D, Hammers A. Automatic anatomical brain MRI segmentation combining label propagation and decision fusion. Neuroimage 2006;33:115-126.
29. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 1997;6:279 -287.
30. Tomasi G, Edison P, Bertoldo A, et al. Novel reference region model reveals increased microglial and reduced vascular binding of 11C-(R)-PK11195 in patients with Alzheimer's disease. J Nucl Med 2008;49:1249 -1256.
31. McColl JH, Holmes AP, Ford I. Statistical methods in neuroimaging with particular application to emission tomography. Stat Methods Med Res 1994;3:63-86.
32. Davalos D, Grutzendler J, Yang G, et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005;8:752-758.
33. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005;308:1314 -1318.
34. Biber K, Neumann H, Inoue K, Boddeke H. Neuronal on and off signals control microglia. Trends Neurosci 2007; 30:596-602.
35. Melton LM, Keith AB, Davis S, Oakley AE, Edwardson JA, Morris CM. Chronic glial activation, neurodegeneration, and APP immunoreactive deposits following acute administration of double-stranded RNA. Glia 2003;44:1-12.
36. Nakanishi H. Microglial functions and proteases. Mol Neurobiol 2003;27:163-176.
37. Taylor DL, Jones F, Kubota E, Pocock JM. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers TNFα-induced neurotoxicity in concert with microglial-derived Fas ligand. J Neurosci 2005;25: 2952-2964.
38. CAMMS223 Trial Investigators, Coles AJ, Compston DA, et al. Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. N Engl J Med 2008;359:1786 -1801.
39. Prinster A, Quarantelli M, Orefice G, et al. Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study. Neuroimage 2006;29:859-867.
40. Ceccarelli A, Rocca MA, Pagani E, et al. A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes. Neuroimage 2008;42: 315-322.